HYSORPTASE
LIVE

Serial Number

79416326

Owner

Shanghai Bao Pharmaceuticals Co.,Ltd.

Attorney

Charles Ho

Filing Date

Nov 11, 2024

Add to watchlist:

No watchlists yet
View on USPTO

HYSORPTASE Trademark

Serial Number: 79416326 • Registration: 8026660

HYSORPTASE is a trademark filed by Shanghai Bao Pharmaceuticals Co.,Ltd. on November 11, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Shanghai Bao Pharmaceuticals Co.,Ltd.

No.28 Luoxin Road,

Entity Type: 99

Trademark Details

Filing Date

November 11, 2024

Registration Date

November 18, 2025

Published for Opposition

September 30, 2025

Goods & Services

Medicines for human purposes for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders; pharmaceutical preparations for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders; drugs for medical purposes for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders; biological preparations for use in cell cultures for medical purposes; enzymes for medical purposes; enzyme preparations for medical purposes; adjuvants for medical purposes; injectable solutions for medical purposes, namely, hyaluronidase in injectable form; aqueous solutions for medical purposes containing recombinant human hyaluronidase for subcutaneous delivery that facilitate the delivery of pharmaceutical preparations; biochemical drugs for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 23, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 6, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 5, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 2, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 13, 2026 FICS
FINAL DISPOSITION PROCESSED
Jun 13, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 18, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 30, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 30, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 24, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 29, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 26, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 26, 2025 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 25, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 25, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 25, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 25, 2025 COAR
REFUSAL PROCESSED BY IB
Jul 12, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 22, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jun 21, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 22, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 21, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 15, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 8, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 8, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 6, 2025 REPR